Exchange: OTC·Updated 07:30 PM EDT
XTLB logo

XTLB XTL Biopharmaceuticals Ltd.

$2.55
$0.16
(6.01%)
Today
Closed $2.50
$0.05
(2.00%)
After Hours
Mkt Cap$10.61M
Vol2,711.00

About XTLB

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
44

Bearish Sentiment

How do you feel about XTLB?

Advertisement|Remove ads.